Oncology drug “value framework” gives doctors, patients a shorthand equation

Article Overview

This article explains an American Society of Clinical Oncology (ASCO) framework for comparing common cancer therapies by combining clinical benefit, toxicity, and cost into a net health benefit assessment. It is aimed at clinicians, patients, and healthcare professionals interested in oncology treatment value, comparative effectiveness, and cost-conscious decision support. The piece summarizes the general purpose of the framework and gives a high-level example of how it is presented in practice.